MedTrace Logo

Duloxetine for Postoperative Pain of Laparoscopic Cholecystectomy

NCT05115123 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-05-16

No results posted yet for this study

Summary

Recent studies on the impact of perioperative duloxetine for treatment of acute postoperative pain have yielded positive outcomes with respect to reduction opioid consumption. The aim of the present study is to investigate the role of perioperative duloxetine on the management of postoperative pain in patients undergoing LC.

Conditions

  • Pain, Postoperative

Interventions

DRUG

Duloxetine

60 mg duloxetine

DRUG

Placebo

Placebo

Sponsors & Collaborators

  • National Hepatology & Tropical Medicine Research Institute

    collaborator OTHER_GOV

  • Mansoura University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-02
Primary Completion
2022-04-30
Completion
2022-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05115123 on ClinicalTrials.gov